| TTM
|
|
|---|---|
| Total Revenue
|
0 |
|
Cost of Revenue
|
0 |
|
Gross Profit
|
0 |
| Selling, General and Administrative Expenses
|
-897.5760 |
|
Research and Development Expenses
|
-463.0650 |
| Depreciation, Amortization and Depletion
|
-54.2700 |
|
Other Income/Expense, Operating
|
114.8410 |
|
Operating Income/Expenses
|
-1,414.9110 |
|
Total Operating Profit/Loss
|
-1,414.9110 |
| Total Net Finance Income/Expense
|
-6.3590 |
| Net Investment Income
|
253.6200 |
| Irregular Income/Expenses
|
1.9320 |
|
Other Income/Expense, Non-Operating
|
0.1230 |
|
Non-Operating Income/Expenses, Total
|
247.3840 |
|
Pretax Income
|
-1,167.5270 |
|
Provision for Income Tax
|
32.2650 |
|
Net Income from Continuing Operations
|
-1,167.5270 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,167.5270 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,167.5270 |
|
Net Income Available to Common Stockholders
|
-1,167.5270 |
|
Diluted Net Income Available to Common Stockholders
|
-1,167.5270 |
| Basic EPS
|
-0.01 |
| Diluted EPS
|
-0.01 |
|
Basic Weighted Average Shares Outstanding
|
85,708.1610 |
|
Diluted Weighted Average Shares Outstanding
|
85,708.1610 |
| Income Statement, Supplemental
|
|
|
EBIT
|
-1,161.1680 |
|
EBITDA
|
-1,106.8980 |
|
Normalized EBITDA
|
-1,237.2460 |
|
Normalized Income
|
-1,297.8750 |
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade